Abiopharma

New Form POS AM - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005766 Size: 20 KB

📋 Michael Leabman (Director and CTO) plans to sell 21K shares of Movano Inc. (at $7.14 each, total $150K) Filed: Jan 07, 2026 | ID: 000021

Alvotech (ALVOW) Files Form 6-K

📋 Tatsis Ourania (Officer) plans to sell 4K shares of VERTEX PHARMACEUTICALS INC / MA (at $474.99 each, total $2.1M) Filed: Jan 07, 2026 | ID: 000179

New Form 25-NSE - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001354457-26-000017 Size: 3 KB

📋 Che Austin (Officer) plans to sell 2K shares of Ginkgo Bioworks Holdings, Inc. (at $9.16 each, total $20K) Filed: Jan 07, 2026 | ID: 000178

BioHarvest Sciences Issues Year End Shareholder Letter

(10% Negative) Enliven Therapeutics, Inc. (IMRA) Announces Delay in trial Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(68% Positive) Sera Prognostics, Inc. (SERA) Announces Enrollment Update for birth Due to Pandemic-Related Challenges, Patient Enrollment Issues, Efficacy Assessment

Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus

Oncolytics Biotech Inc (ONCY) Files Form 6-K

DexCom, Inc. - Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

Tenet - Tenet to Report its Fourth Quarter 2025 Results on February 11th

Masimo - Masimo to Present in the J.P. Morgan 2026 Healthcare Conference

Codexis Expands Reach of the ECO Synthesis®Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics